This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
This Funds tag curates 4 recent articles on funds strategies, market moves, and portfolio impact. Discover actionable ideas to diversify and strengthen your financial plan.
5 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A fund boosted its education exposure by 84%, pushing its stake toward the $6 million mark. This article breaks down ...
JPMorgan Chase is tightening its lending standards for private deals while a $33 billion private credit fund faces he...
A major fund disclosed a sizable NEU share sale. This article unpacks what the move signals, how to interpret it, and...
When a fund exits its Brookdale Senior Living stake, it raises questions about momentum and risk. This guide breaks d...